{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-101595","form_type":"8-K","ticker":null,"cik":"0001173281","company_name":"NeuBase Therapeutics, Inc.","filed_at":"2023-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.298317+00:00","generated_at":"2026-06-10T14:30:33.340759+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"NeuBase Therapeutics lowers stockholder meeting quorum to one-third of shares","bullets":["Board approved bylaw amendment effective September 15, 2023.","Quorum changed to one-third of shares outstanding and entitled to vote.","Amendment intended to improve ability to hold stockholder meetings."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-101595","json":"https://secwatch.observer/filing/0001104659-23-101595.json","markdown":"https://secwatch.observer/filing/0001104659-23-101595.md","text":"https://secwatch.observer/filing/0001104659-23-101595.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173281/000110465923101595/0001104659-23-101595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173281/000110465923101595/tm2326323d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T14:30:33.340759+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"778ef0d13271205e196f05a9ff3413b1aa8d6962","claim":"NeuBase Therapeutics, Inc.: Changed quorum requirement for stockholder meetings to one-third of outstanding shares entitled to vote (effective 2023-09-15).","evidence_excerpt":"On September 15, 2023, the Board of Directors of NeuBase Therapeutics, Inc. (the “Company”) approved an amendment of the Company’s Amended and Restated Bylaws (the “Bylaws”), effective as of September 15, 2023, to change the quorum for the transaction of business at stockholder meetings to one-third of the shares of stock outstanding and entitled to vote at the meeting.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173281/000110465923101595/0001104659-23-101595-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-09-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}